|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM049609882 |
| 003 |
DE-627 |
| 005 |
20250127162902.0 |
| 007 |
tu |
| 008 |
231221s1969 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed25n0166.xml
|
| 035 |
|
|
|a (DE-627)NLM049609882
|
| 035 |
|
|
|a (NLM)4981631
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Maeda, Y
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Oral administration of cephalosporin C
|b Its clinical evaluation with double blind method
|
| 264 |
|
1 |
|c 1969
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 22.12.1969
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Clinical Trial
|
| 650 |
|
4 |
|a Comparative Study
|
| 650 |
|
4 |
|a Controlled Clinical Trial
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Cephalosporins
|2 NLM
|
| 650 |
|
7 |
|a Ampicillin
|2 NLM
|
| 650 |
|
7 |
|a 7C782967RD
|2 NLM
|
| 700 |
1 |
|
|a Omori, T
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 15(1969), 9 vom: 01. Sept., Seite 670-6
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnas
|
| 773 |
1 |
8 |
|g volume:15
|g year:1969
|g number:9
|g day:01
|g month:09
|g pages:670-6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 15
|j 1969
|e 9
|b 01
|c 09
|h 670-6
|